Treelet Health provides the latest health news, disease prevention, nutrition and diet, and other professional health knowledge to help you maintain a healthy lifestyle.
Scientists have developed a novel blood test that can predict the likelihood of an individual developing Alzheimer's symptoms within approximately 3-4 years by measuring levels of the p-tau217 protein in plasma. This technology holds promise for accelerating preventive drug trials and providing a crucial tool for future personalized interventions.
A growing body of scientific research suggests a significant link between the microbial communities in our gut (gut microbiota) and heart health. These tiny 'residents' not only influence digestion but may also profoundly impact cardiovascular disease risk through metabolites and immune system regulation. This article explores the potential connections between gut microbiota and heart health.
The supplement market is vast, but not all pills are necessary for everyone. Based on expert insights, this article examines 10 common supplements, discusses their necessity for the general healthy population, and suggests that obtaining nutrients through a balanced diet is often a better approach.
New research reveals significant parallels in cancer development between domestic cats and humans, particularly regarding a specific gene mutation in breast cancer. This discovery provides a valuable model for developing new treatments for rare but aggressive cancers, promising a win-win for both human and veterinary medicine.
Intermittent fasting has gained significant attention, but can results from animal studies be directly applied to humans? This article explores its potential health benefits, such as weight management and improved metabolism, while also highlighting limitations like individual differences and unclear long-term effects, offering practical safety advice.
New research suggests that three existing medications, including sildenafil (commonly known as Viagra), may help prevent or treat Alzheimer's disease. This finding offers a promising new avenue for developing faster and more cost-effective treatments for dementia.
A new study pooling data from over 17,000 cancer survivors found that becoming more active after a diagnosis, even if previously inactive, significantly reduces mortality risk. Experts emphasize that physical activity positively impacts patient well-being and cancer trajectory before, during, and after treatment.
Eli Lilly has released new long-term data for its drug Omvoh (mirikizumab) in moderately to severely active Crohn's disease. The results show that over 90% of patients who achieved steroid-free remission at one year maintained it through three years of continuous treatment. Additionally, the drug significantly reduced hospitalization and surgery rates in both Crohn's disease and ulcerative colitis patients, highlighting its potential to alter the long-term disease trajectory.
A trial conducted by researchers in the UK and Sweden found that having healthcare workers who experienced trauma play Tetris while briefly recalling the traumatic event can effectively reduce subsequent intrusive memories and flashbacks. This method, known as Imagery Competing Task Intervention, offers a novel, accessible, non-pharmacological approach to addressing post-traumatic stress.
A major study led by the University of Exeter has identified three existing drugs—a shingles vaccine, sildenafil (Viagra), and riluzole—that show surprising promise in the fight against Alzheimer's disease. Among them, the shingles vaccine was highlighted as the most promising candidate by an expert panel. This research opens a new pathway for faster and safer dementia treatment development through drug repurposing.
Cardiovascular disease is a leading cause of death for women worldwide, yet its symptoms, risk factors, and diagnostic criteria often differ from those in men. This article explores the unique challenges in women's cardiovascular health, emphasizing the need for personalized care based on sex differences to improve prevention, diagnosis, and treatment outcomes.
A study published in Molecular Psychiatry, integrating human brain gene expression data with fruit fly model experiments, reveals the molecular cascade of events in Alzheimer's disease—from amyloid plaques and tau tangles to neurodegeneration and cognitive decline. The research identified pathways that may aggravate the disease and others that could be protective, offering crucial insights for developing new therapies.